4//SEC Filing
James Andrea S. 4
Accession 0001493152-24-024981
CIK 0001642380other
Filed
Jun 23, 8:00 PM ET
Accepted
Jun 24, 4:49 PM ET
Size
12.0 KB
Accession
0001493152-24-024981
Insider Transaction Report
Form 4
James Andrea S.
Chief Financial Officer
Transactions
- Award
Restricted Stock Units
2024-06-20+100,000→ 300,000 total→ Common Stock (100,000 underlying) - Award
Option to Purchase Common Stock
2024-06-20+200,000→ 200,000 totalExercise: $2.87→ Common Stock (200,000 underlying)
Footnotes (3)
- [F1]Granted on June 20, 2024 (the "Grant Date"), but such award is subject to shareholder approval of an increase in the number of shares available for issuance under the Oncocyte 2018 Equity Incentive Plan. Following such shareholder approval, an additional Form 4 will be filed with respect to the grant in accordance with pursuant to Section 16(a) of the Securities Exchange Act of 1934, as amended.
- [F2]The Option shall vest as follows, subject to the Reporting Person's continued compliance with any restrictive covenants by which the Reporting Person may be bound and continuous service as an employee of the Issuer or a Subsidiary from June 17, 2024, through the applicable vesting date: (A) twenty-five percent (25%) of the shares subject to the Option will vest and thereby become exercisable upon the one-year anniversary of the Grant Date, and (B) 75% of the shares subject to the Option will vest in thirty-six (36) substantially equal monthly installments thereafter.
- [F3]See Exhibit 99 attached hereto.
Documents
Issuer
Oncocyte Corp
CIK 0001642380
Entity typeother
Related Parties
1- filerCIK 0002027010
Filing Metadata
- Form type
- 4
- Filed
- Jun 23, 8:00 PM ET
- Accepted
- Jun 24, 4:49 PM ET
- Size
- 12.0 KB